Is ANL or APGE more undervalued in 2026?

CirclFi compares Adlai Nortye Ltd. (ANL) and Apogee Therapeutics, Inc. (APGE) using 13 institutional-grade valuation models. ANL has a Quality of Company score of 1.5/10 while APGE scores 4.2/10.

Which is a better buy — ANL or APGE?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do ANL and APGE valuations compare?

ANL at $11.30 and APGE at $77.82 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

ANL vs APGE Valuation Comparison 2026 — Intrinsic Value Analysis

ANL

Biotechnology

Adlai Nortye Ltd.

Quality

1.5

out of 10

Value Trap

SAFE

Price

$11.30

Last close

Models

9/13

Active

APGE

Biotechnology

Apogee Therapeutics, Inc.

Quality

4.2

out of 10

Value Trap

SAFE

Price

$77.82

Last close

Models

10/13

Active

Model-by-Model Comparison

Model	Type	ANL Fair Value	ANL Upside	APGE Fair Value	APGE Upside
Bayesian DCF	Intrinsic	$2.99	-73.5%	$26.30	-66.2%
Earnings Power Value	Intrinsic	—	—	$37.75	-55.9%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
Markov DDM	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$7.86	-49.3%	—	—

🔒

Unlock Full 13-Model Comparison

Access all valuation models for ANL vs APGE — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

ANL vs APGE — Which Stock Is More Undervalued?

APGE scores higher with a 4.2/10 quality rating vs ANL's 1.5/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Adlai Nortye Ltd. (ANL) and Apogee Therapeutics, Inc. (APGE) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

ANL currently trades at $11.30 with a QOC of 1.5/10, while APGE trades at $77.82 with a QOC of 4.2/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).